Jack W. Lasersohn

This profile gathers the share dealings of Jack W. Lasersohn across 5 companies, led by OncoMed Pharmaceuticals Inc, Yield10 Bioscience, Inc. and Masimo Corp. In total, 124 filings cover trades dated from 4 August 2005 to 17 September 2024.

On the open market, the record shows 11 purchases worth €645k and 64 sales worth €77.4M. The net balance comes to €76.8M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 share grants.

Half of the purchases are above €42k and half below. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 18 September 2024 came the latest disclosure, a transaction in Silk Road Medical Inc. The last purchase on record was published on 26 May 2017, which is 3,437 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.